A. Lueck

545 total citations
7 papers, 435 citations indexed

About

A. Lueck is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cell Biology. According to data from OpenAlex, A. Lueck has authored 7 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in A. Lueck's work include Renal cell carcinoma treatment (2 papers), Cellular Mechanics and Interactions (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). A. Lueck is often cited by papers focused on Renal cell carcinoma treatment (2 papers), Cellular Mechanics and Interactions (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). A. Lueck collaborates with scholars based in Germany and United States. A. Lueck's co-authors include Henry B. Warren, Peter Marks, Hiroaki Onda, David J. Kwiatkowski, Dennis Brown, Philip G. Allen, Helen L. Yin, Frank Meyer, Karsten Ridwelski and H. Lippert and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

A. Lueck

7 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Lueck Germany	5	260	216	83	83	71	7	435
P. Wong United States	9	213 0.8×	139 0.6×	46 0.6×	74 0.9×	51 0.7×	16	419
Nacéra Saadane Canada	9	282 1.1×	177 0.8×	33 0.4×	44 0.5×	25 0.4×	12	548
Tsuneo Kido Japan	8	316 1.2×	90 0.4×	124 1.5×	80 1.0×	27 0.4×	9	465
Cathrine K. Fog Denmark	10	271 1.0×	84 0.4×	74 0.9×	53 0.6×	30 0.4×	15	437
Joseph Nahmias United Kingdom	9	278 1.1×	248 1.1×	102 1.2×	20 0.2×	60 0.8×	12	534
Katrin Marschner Germany	9	174 0.7×	156 0.7×	19 0.2×	156 1.9×	63 0.9×	9	472
Nandini V. L. Hayes United Kingdom	12	247 0.9×	81 0.4×	58 0.7×	87 1.0×	32 0.5×	23	351
Norihisa Shindo Japan	10	221 0.8×	67 0.3×	29 0.3×	92 1.1×	115 1.6×	22	338
César Márquez United States	8	134 0.5×	120 0.6×	64 0.8×	33 0.4×	49 0.7×	11	312
John C. Winkelmann United States	11	186 0.7×	170 0.8×	19 0.2×	43 0.5×	83 1.2×	13	390

Countries citing papers authored by A. Lueck

Since Specialization

Citations

This map shows the geographic impact of A. Lueck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lueck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lueck more than expected).

Fields of papers citing papers by A. Lueck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lueck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lueck. The network helps show where A. Lueck may publish in the future.

Co-authorship network of co-authors of A. Lueck

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lueck. A scholar is included among the top collaborators of A. Lueck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lueck. A. Lueck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mueller, Lothar, et al.. (2014). Sequential treatment of advanced or metastatic renal cell carcinoma (mRCC): What is effective? Data from the German RCC registry.. Journal of Clinical Oncology. 32(4_suppl). 499–499. 1 indexed citations

2.

Schindler, Antonio, et al.. (2013). ICU personnel have inaccurate perceptions of their patients' experiences. Acta Anaesthesiologica Scandinavica. 57(8). 1032–1040. 12 indexed citations

3.

Mueller, Lothar, et al.. (2011). Real-life treatment of patients with advanced or metastatic renal cell carcinoma in German oncology and urology outpatient centers (RCC-Registry).. Journal of Clinical Oncology. 29(7_suppl). 367–367. 1 indexed citations

4.

Meyer, Frank, et al.. (2004). Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma. Chemotherapy. 50(6). 289–296. 11 indexed citations

5.

Lueck, A., Helen L. Yin, David J. Kwiatkowski, & Philip G. Allen. (2000). Calcium Regulation of Gelsolin and Adseverin: A Natural Test of the Helix Latch Hypothesis. Biochemistry. 39(18). 5274–5279. 37 indexed citations

6.

Onda, Hiroaki, et al.. (1999). Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. Journal of Clinical Investigation. 104(6). 687–695. 309 indexed citations

7.

Lueck, A., Dennis Brown, & David J. Kwiatkowski. (1998). The actin-binding proteins adseverin and gelsolin are both highly expressed but differentially localized in kidney and intestine. Journal of Cell Science. 111(24). 3633–3643. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact